(Q45889454)

17 December 2017

title

Chemosensitivity of human malignant glioma: modulation by p53 gene transfer (English)

1 reference

17 December 2017

author

Erich Gulbins

4

1 reference

17 December 2017

author name string

M Trepel

1

1 reference

17 December 2017

P Groscurth

2

1 reference

17 December 2017

U Malipiero

3

1 reference

17 December 2017

J Dichgans

5

1 reference

17 December 2017

M Weller

6

1 reference

17 December 2017

publication date

1 August 1998

1 reference

17 December 2017

Journal of Neuro-Oncology

published in

1 reference

17 December 2017

volume

39

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

19-32

1 reference

17 December 2017

Tumor suppressor p53 mutations and breast cancer: a critical analysis

cites work

1 reference

12 December 2020

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines

1 reference

12 December 2020

Negative feedback regulation of wild-type p53 biosynthesis.

1 reference

12 December 2020

Wild-type p53 regulates its own transcription in a cell-type specific manner

1 reference

12 December 2020

Identification of a p53-dependent negative response element in the bcl-2 gene

1 reference

12 December 2020

Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

1 reference

12 December 2020

P53 and induction of apoptosis as a target for anticancer therapy.

1 reference

12 December 2020

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.

1 reference

12 December 2020

p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

1 reference

12 December 2020

p53 mutations, O6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors

1 reference

12 December 2020

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

1 reference

12 December 2020

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer

1 reference

12 December 2020

Apoptosis, cancer and the p53 tumour suppressor gene

1 reference

12 December 2020

In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug

1 reference

12 December 2020

p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs

1 reference

12 December 2020

mdm2 expression is induced by wild type p53 activity

1 reference

12 December 2020

A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice

1 reference

12 December 2020

Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis

1 reference

12 December 2020

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

12 December 2020

Clinical implications of the p53 gene

1 reference

12 December 2020

Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression

1 reference

12 December 2020

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes

1 reference

12 December 2020

Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis

1 reference

12 December 2020

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

1 reference

12 December 2020

p53 is required for radiation-induced apoptosis in mouse thymocytes

1 reference

12 December 2020

Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression

1 reference

12 December 2020

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

1 reference

12 December 2020

The basis for current treatment recommendations for malignant gliomas

1 reference

12 December 2020

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

1 reference

12 December 2020

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

12 December 2020

Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells

1 reference

12 December 2020

Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53

1 reference

12 December 2020

Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats

1 reference

12 December 2020

The p53-mdm-2 autoregulatory feedback loop

1 reference

12 December 2020

Negative regulation of Rb expression by the p53 gene product

1 reference

12 December 2020

Human wild type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines in vitro

1 reference

12 December 2020

Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity.

1 reference

12 December 2020

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53

1 reference

12 December 2020

The p53 gene and its role in human brain tumors.

1 reference

12 December 2020

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

12 December 2020

Comparative study of p53 gene and protein alterations in human astrocytic tumors

1 reference

12 December 2020

Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genes.

1 reference

12 December 2020

Analysis of the p53 gene and its expression in human glioblastoma cells

1 reference

12 December 2020

Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.

1 reference

12 December 2020

Induction of apoptosis in HeLa cells by trans-activation-deficient p53

1 reference

12 December 2020

MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis

1 reference

12 December 2020

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

12 December 2020

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

1 reference

12 December 2020

Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells

1 reference

12 December 2020

c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle

1 reference

12 December 2020

Wild-type p53 demonstrates functional dominance in a human colon carcinoma cell line in which it induces reversible growth arrest.

1 reference

12 December 2020

In vivo gene therapy with p53 or p21 adenovirus for prostate cancer

1 reference

12 December 2020

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

12 December 2020

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

1 reference

12 December 2020

Management of primary malignant brain tumours

1 reference

12 December 2020

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

12 December 2020

p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005910323338

1 reference

17 December 2017

Dimensions Publication ID

1038059902

0 references

1 reference

17 December 2017